Drawing for MINDGENICS

USPTO serial 98523480

MINDGENICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MINDGENICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher J. Day

Christopher J. Day Day Law Firm9977 N 90th St Ste 155Scottsdale, AZ 85258United States

Goods and services

ClassDescriptionStatusFirst use
005Nutritional supplements; Nutritional supplements consisting primarily of mushroom ingredients; Nutritional supplements consisting primarily of nootropics; Nutritional supplements in the form of powder; Nutritional supplements in the form of capsulesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 10, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 10, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 16, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 16, 2025EX2GSOU EXTENSION 2 GRANTED—
Dec 15, 2025EXT2SOU EXTENSION 2 FILED—
Dec 15, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 2, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 1, 2025EX1GSOU EXTENSION 1 GRANTED—
Jul 1, 2025EXT1SOU EXTENSION 1 FILED—
Jul 1, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 30, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 29, 2024DOCKASSIGNED TO EXAMINER—
Apr 28, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 28, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance